KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Operating Expenses (2017 - 2025)

Guardant Health's Operating Expenses history spans 9 years, with the latest figure at $402.1 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 22.67% year-over-year to $402.1 million; the TTM value through Dec 2025 reached $1.4 billion, up 20.01%, while the annual FY2025 figure was $1.4 billion, 20.01% up from the prior year.
  • Operating Expenses for Q4 2025 was $402.1 million at Guardant Health, up from $364.2 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $402.1 million in Q4 2025 and bottomed at $186.5 million in Q1 2021.
  • The 5-year median for Operating Expenses is $265.5 million (2023), against an average of $275.5 million.
  • The largest annual shift saw Operating Expenses soared 82.12% in 2021 before it fell 7.03% in 2024.
  • A 5-year view of Operating Expenses shows it stood at $206.3 million in 2021, then soared by 32.33% to $273.0 million in 2022, then grew by 29.14% to $352.6 million in 2023, then fell by 7.03% to $327.8 million in 2024, then rose by 22.67% to $402.1 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Operating Expenses are $402.1 million (Q4 2025), $364.2 million (Q3 2025), and $338.5 million (Q2 2025).